Himadri Speciality Chemical Share Price
Sector: Chemical Manufacturing
451.80 -4.05 (-0.89%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
445.50
Today’s High
460.90
52 Week Low
307.30
52 Week High
688.50
452.15 -3.55 (-0.78%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
445.20
Today’s High
460.75
52 Week Low
307.70
52 Week High
688.70
Key Metrics
- Market Cap (In Cr) 22297.18
- Beta 0.97
- Div. Yield (%) 0.13
- P/B 6.05
- TTM P/E 37.69
- Peg Ratio 0.32
- Sector P/E 17.96
- D/E 0
- Open Price 455.35
- Prev Close 455.85
Himadri Speciality Chemical Analysis
Price Analysis
-
1 Week-1.59%
-
3 Months-11.35%
-
6 Month-17.57%
-
YTD-22.06%
-
1 Year23.97%
Risk Meter
- 43% Low risk
- 43% Moderate risk
- 43% Balanced Risk
- 43% High risk
- 43% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 0.00
- 0.00
- 0.00
- 0.00
- Buy
- 2
- 2
- 2
- 2
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 2
- 2
- 2
- 2
Himadri Speciality Chemical News
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 25 Mar 2025Buy or sell: Vaishali Parekh recommends three stocks to buy today — 24 March
2 min read . 24 Mar 2025Osho Krishan of Angel One suggests these two stocks to buy today - 27 Feb 2025
3 min read . 27 Feb 2025Himadri Speciality Chemical Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 4612.63
- Selling/ General/ Admin Expenses Total
- 139.39
- Depreciation/ Amortization
- 54.97
- Other Operating Expenses Total
- 471.99
- Total Operating Expense
- 3813.38
- Operating Income
- 799.25
- Net Income Before Taxes
- 806.17
- Net Income
- 555.62
- Diluted Normalized EPS
- 11.26
- Period
- 2025
- Total Assets
- 4656.01
- Total Liabilities
- 934.27
- Total Equity
- 3721.74
- Tangible Book Valueper Share Common Eq
- 73.72
- Period
- 2025
- Cashfrom Operating Activities
- 446.87
- Cashfrom Investing Activities
- -235.21
- Cashfrom Financing Activities
- -271.49
- Net Changein Cash
- -59.84
- Period
- 2024
- Total Revenue
- 4184.89
- Selling/ General/ Admin Expenses Total
- 418.94
- Depreciation/ Amortization
- 49.86
- Other Operating Expenses Total
- 90.99
- Total Operating Expense
- 3599.15
- Operating Income
- 585.74
- Net Income Before Taxes
- 573.86
- Net Income
- 410.77
- Diluted Normalized EPS
- 9.16
- Period
- 2024
- Total Assets
- 4448.79
- Total Liabilities
- 1403.21
- Total Equity
- 3045.58
- Tangible Book Valueper Share Common Eq
- 61.81
- Period
- 2024
- Cashfrom Operating Activities
- 404.76
- Cashfrom Investing Activities
- -404.86
- Cashfrom Financing Activities
- 7.19
- Net Changein Cash
- 7.08
- Period
- 2023
- Total Revenue
- 4171.84
- Selling/ General/ Admin Expenses Total
- 414.73
- Depreciation/ Amortization
- 50.85
- Other Operating Expenses Total
- 76.6
- Total Operating Expense
- 3832.8
- Operating Income
- 339.05
- Net Income Before Taxes
- 280.25
- Net Income
- 215.98
- Diluted Normalized EPS
- 5.68
- Period
- 2023
- Total Assets
- 3678.13
- Total Liabilities
- 1397.62
- Total Equity
- 2280.51
- Tangible Book Valueper Share Common Eq
- 52.69
- Period
- 2023
- Cashfrom Operating Activities
- 53.96
- Cashfrom Investing Activities
- -396.66
- Cashfrom Financing Activities
- 377.11
- Net Changein Cash
- 34.42
- Period
- 2022
- Total Revenue
- 2791.32
- Selling/ General/ Admin Expenses Total
- 325.64
- Depreciation/ Amortization
- 74.2
- Other Operating Expenses Total
- 46.9
- Total Operating Expense
- 2701.74
- Operating Income
- 89.57
- Net Income Before Taxes
- 53.47
- Net Income
- 40.95
- Diluted Normalized EPS
- 0.98
- Period
- 2022
- Total Assets
- 3453.83
- Total Liabilities
- 1586.2
- Total Equity
- 1867.64
- Tangible Book Valueper Share Common Eq
- 44.56
- Period
- 2022
- Cashfrom Operating Activities
- 330.88
- Cashfrom Investing Activities
- -28.23
- Cashfrom Financing Activities
- -181.98
- Net Changein Cash
- 120.67
- Period
- 2021
- Total Revenue
- 1679.46
- Selling/ General/ Admin Expenses Total
- 273.36
- Depreciation/ Amortization
- 46.97
- Other Operating Expenses Total
- 35.17
- Total Operating Expense
- 1594.64
- Operating Income
- 84.82
- Net Income Before Taxes
- 64.56
- Net Income
- 47.48
- Diluted Normalized EPS
- 1.13
- Period
- 2021
- Total Assets
- 2791.17
- Total Liabilities
- 998.26
- Total Equity
- 1792.91
- Tangible Book Valueper Share Common Eq
- 42.76
- Period
- 2021
- Cashfrom Operating Activities
- -40.41
- Cashfrom Investing Activities
- -113.56
- Cashfrom Financing Activities
- 164.66
- Net Changein Cash
- 10.69
- Period
- 2020
- Total Revenue
- 1805.8
- Selling/ General/ Admin Expenses Total
- 238.79
- Depreciation/ Amortization
- 39.24
- Other Operating Expenses Total
- 44.89
- Total Operating Expense
- 1550.16
- Operating Income
- 255.64
- Net Income Before Taxes
- 194.15
- Net Income
- 205.48
- Diluted Normalized EPS
- 3.24
- Period
- 2020
- Total Assets
- 2562.42
- Total Liabilities
- 828.27
- Total Equity
- 1734.15
- Tangible Book Valueper Share Common Eq
- 41.36
- Period
- 2020
- Cashfrom Operating Activities
- 282.59
- Cashfrom Investing Activities
- -213.75
- Cashfrom Financing Activities
- -40.79
- Net Changein Cash
- 27.97
- Period
- 2019
- Total Revenue
- 2422.39
- Selling/ General/ Admin Expenses Total
- 216.34
- Depreciation/ Amortization
- 34.43
- Other Operating Expenses Total
- 42.29
- Total Operating Expense
- 1896.96
- Operating Income
- 525.43
- Net Income Before Taxes
- 462.14
- Net Income
- 324.29
- Diluted Normalized EPS
- 7.74
- Period
- 2019
- Total Assets
- 2787.9
- Total Liabilities
- 1156.11
- Total Equity
- 1631.79
- Tangible Book Valueper Share Common Eq
- 38.93
- Period
- 2019
- Cashfrom Operating Activities
- 475.83
- Cashfrom Investing Activities
- -224.23
- Cashfrom Financing Activities
- -257.44
- Net Changein Cash
- -5.84
- Period
- 2018
- Total Revenue
- 2071.85
- Selling/ General/ Admin Expenses Total
- 164.33
- Depreciation/ Amortization
- 33.23
- Other Operating Expenses Total
- 36.18
- Total Operating Expense
- 1652.69
- Operating Income
- 419.16
- Net Income Before Taxes
- 360.97
- Net Income
- 247.46
- Diluted Normalized EPS
- 5.91
- Period
- 2018
- Total Assets
- 2416.27
- Total Liabilities
- 1001.61
- Total Equity
- 1414.66
- Tangible Book Valueper Share Common Eq
- 33.75
- Period
- 2018
- Cashfrom Operating Activities
- 258.07
- Cashfrom Investing Activities
- -50.34
- Cashfrom Financing Activities
- -199.88
- Net Changein Cash
- 7.84
- Period
- 2025-03-31
- Total Revenue
- 1134.64
- Selling/ General/ Admin Expenses Total
- 35.68
- Depreciation/ Amortization
- 13.72
- Other Operating Expenses Total
- 121.09
- Total Operating Expense
- 915.05
- Operating Income
- 219.59
- Net Income Before Taxes
- 224.35
- Net Income
- 155.58
- Diluted Normalized EPS
- 3.15
- Period
- 2025-03-31
- Total Assets
- 4656.01
- Total Liabilities
- 934.27
- Total Equity
- 3721.74
- Tangible Book Valueper Share Common Eq
- 73.72
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 446.87
- Cashfrom Investing Activities
- -235.21
- Cashfrom Financing Activities
- -271.49
- Net Changein Cash
- -59.84
- Period
- 2024-12-31
- Total Revenue
- 1140.66
- Selling/ General/ Admin Expenses Total
- 37.43
- Depreciation/ Amortization
- 15.22
- Other Operating Expenses Total
- 119.43
- Total Operating Expense
- 935.02
- Operating Income
- 205.64
- Net Income Before Taxes
- 205.84
- Net Income
- 142.06
- Diluted Normalized EPS
- 2.85
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 1136.92
- Selling/ General/ Admin Expenses Total
- 34.82
- Depreciation/ Amortization
- 13.1
- Other Operating Expenses Total
- 104.21
- Total Operating Expense
- 941.89
- Operating Income
- 195.03
- Net Income Before Taxes
- 197.3
- Net Income
- 135.36
- Diluted Normalized EPS
- 2.72
- Period
- 2024-09-30
- Total Assets
- 4477.12
- Total Liabilities
- 1067.55
- Total Equity
- 3409.57
- Tangible Book Valueper Share Common Eq
- 68.16
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 176.9
- Cashfrom Investing Activities
- -115.69
- Cashfrom Financing Activities
- -220.59
- Net Changein Cash
- -159.31
- Period
- 2024-06-30
- Total Revenue
- 1200.41
- Selling/ General/ Admin Expenses Total
- 31.46
- Depreciation/ Amortization
- 12.93
- Other Operating Expenses Total
- 127.26
- Total Operating Expense
- 1021.42
- Operating Income
- 178.99
- Net Income Before Taxes
- 178.68
- Net Income
- 122.62
- Diluted Normalized EPS
- 2.48
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 1176.95
- Selling/ General/ Admin Expenses Total
- 29.59
- Depreciation/ Amortization
- 12.61
- Other Operating Expenses Total
- 117.49
- Total Operating Expense
- 1010.06
- Operating Income
- 166.89
- Net Income Before Taxes
- 165.73
- Net Income
- 115.16
- Diluted Normalized EPS
- 2.4
- Period
- 2024-03-31
- Total Assets
- 4448.79
- Total Liabilities
- 1403.21
- Total Equity
- 3045.58
- Tangible Book Valueper Share Common Eq
- 61.81
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 404.76
- Cashfrom Investing Activities
- -404.86
- Cashfrom Financing Activities
- 7.19
- Net Changein Cash
- 7.08
- Period
- 2023-12-31
- Total Revenue
- 1052.51
- Selling/ General/ Admin Expenses Total
- 26.89
- Depreciation/ Amortization
- 12.72
- Other Operating Expenses Total
- 97.27
- Total Operating Expense
- 891.33
- Operating Income
- 161.18
- Net Income Before Taxes
- 150.15
- Net Income
- 108.82
- Diluted Normalized EPS
- 2.47
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 1004.52
- Selling/ General/ Admin Expenses Total
- 28.22
- Depreciation/ Amortization
- 12.43
- Other Operating Expenses Total
- 94.05
- Total Operating Expense
- 859.29
- Operating Income
- 145.23
- Net Income Before Taxes
- 139.1
- Net Income
- 100.64
- Diluted Normalized EPS
- 2.29
- Period
- 2023-09-30
- Total Assets
- 4236.04
- Total Liabilities
- 1692.25
- Total Equity
- 2543.79
- Tangible Book Valueper Share Common Eq
- 57.8
- Period
- 2023-09-30
- Cashfrom Operating Activities
- -266.15
- Cashfrom Investing Activities
- -93.21
- Cashfrom Financing Activities
- 195.75
- Net Changein Cash
- -163.61
- Period
- 2023-06-30
- Total Revenue
- 950.91
- Selling/ General/ Admin Expenses Total
- 25.78
- Depreciation/ Amortization
- 12.1
- Other Operating Expenses Total
- 90.26
- Total Operating Expense
- 829
- Operating Income
- 121.91
- Net Income Before Taxes
- 118.88
- Net Income
- 86.15
- Diluted Normalized EPS
- 1.99
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 1028.9
- Selling/ General/ Admin Expenses Total
- 21.53
- Depreciation/ Amortization
- 12.32
- Other Operating Expenses Total
- 100.78
- Total Operating Expense
- 915.67
- Operating Income
- 113.23
- Net Income Before Taxes
- 110.59
- Net Income
- 76.26
- Diluted Normalized EPS
- 1.79
- Period
- 2023-03-31
- Total Assets
- 3678.13
- Total Liabilities
- 1397.62
- Total Equity
- 2280.51
- Tangible Book Valueper Share Common Eq
- 52.69
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 53.96
- Cashfrom Investing Activities
- -396.66
- Cashfrom Financing Activities
- 377.11
- Net Changein Cash
- 34.42
- Period
- 2022-12-31
- Total Revenue
- 1037.39
- Selling/ General/ Admin Expenses Total
- 21.11
- Depreciation/ Amortization
- 12.85
- Other Operating Expenses Total
- 91.24
- Total Operating Expense
- 945.34
- Operating Income
- 92.05
- Net Income Before Taxes
- 79.47
- Net Income
- 65.19
- Diluted Normalized EPS
- 1.55
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Himadri Speciality Chemical Technical
Moving Average
SMA
- 5 Day469.87
- 10 Day455.08
- 20 Day443.4
- 50 Day435.62
- 100 Day489.57
- 300 Day507.84
Himadri Speciality Chemical Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Deepak Nitrite
- 1979.95
- 19.1
- 0.97
- 3168.65
- 1780.5
- 27083.18
- Sumitomo Chemical India
- 510.2
- -3.15
- -0.61
- 628
- 380.05
- 25382.36
- Himadri Speciality Chemical
- 451.8
- -4.05
- -0.89
- 688.5
- 307.3
- 22297.18
- Navin Fluorine International
- 4460.85
- 15.2
- 0.34
- 4560
- 2876.45
- 22122.15
- Bayer Cropscience
- 4785
- -106.2
- -2.17
- 7189.9
- 4220.05
- 21620.38
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Deepak Nitrite
- 35.65
- 5.58
- 28.82
- 13.26
- Sumitomo Chemical India
- 69.29
- 10.48
- 20.93
- 12.74
- Himadri Speciality Chemical
- 40.47
- 6.05
- 10.85
- 7.27
- Navin Fluorine International
- 96.36
- 9.26
- 17.89
- 19.87
- Bayer Cropscience
- 29.06
- 7.72
- 24.11
- 13.62
Himadri Speciality Chemical Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 21-Apr-25
- Audited Results & Dividend
- 13-Jan-25
- Quarterly Results
- 16-Oct-24
- Quarterly Results
- 16-Jul-24
- Quarterly Results
- 25-Apr-24
- Audited Results & Final Dividend
- 20-Mar-24
- Others
- 16-Jan-24
- Quarterly Results
- 17-Oct-23
- Quarterly Results
- 18-Jul-23
- Quarterly Results
- 28-Apr-23
- Audited Results & Final Dividend
- Meeting Date
- Announced on
- Purpose
- 20-Jun-24
- 28-May-24
- AGM
- 22-Jun-23
- 24-May-23
- AGM
- 26-Mar-23
- 20-Feb-23
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 21-Apr-25
- -
- -
- 0.6
- 25-Apr-24
- -
- 07-Jun-24
- 0.5
- 28-Apr-23
- -
- 09-Jun-23
- 0.25
- 21-Jul-22
- -
- 20-Sept-22
- 0.2
- 30-Jun-21
- -
- 21-Sept-21
- 0.15


